• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由胶孢炭疽菌合成的纳米粒子对致病性大肠杆菌的抗菌、抗生物膜和抗毒力作用。

Antibacterial, antibiofilm, and antivirulence effects of nanoparticles synthesized from Colletotrichum gloeosporioides in pathogenic E.coli.

机构信息

School of Life Sciences, B. S. Abdur Rahman Crescent Institute of Science and Technology, Vandalur, Chennai, 600048, India.

School of Life Sciences, B. S. Abdur Rahman Crescent Institute of Science and Technology, Vandalur, Chennai, 600048, India.

出版信息

Microb Pathog. 2023 Dec;185:106420. doi: 10.1016/j.micpath.2023.106420. Epub 2023 Oct 23.

DOI:10.1016/j.micpath.2023.106420
PMID:37879451
Abstract

Antimicrobial resistance is a global problem and antibiotics are becoming ineffective due to the resistance developed by bacteria. In this current research, silver nanoparticles were synthesized from aqueous extract of endophytic fungi Colletotrichum gloeosporioides (CgAgNPs) and characterized by various methods. CgAgNPs efficacy was analyzed by performing antimicrobial assays in Escherichia coli ATCC 25922 and antibiotic resistant pathogenic strains. Upon treatment with CgAgNPs biofilm formation was reduced in all E.coli strains. In vitro cytotoxicity assays revealed that CgAgNPs were able to increase the membrane permeability and induced leakage of sugars and proteins. CgAgNPs induced oxidative stress in E. coli strains led to lipid peroxidation and release of malonaldehyde. The CgAgNPs were able to modulate the anti-oxidant system of cells hence there was a reduction in Glutathione reductase, Catalase and Superoxide dismutase enzymes activities. Analysis of expression of gene encoding CTX-M-15 showed the down regulation upon treatment with ampicillin and CgAgNPs. Overall, the results suggest that CgAgNPs control growth, biofilm formation in E. coli through induction of oxidative stress, interference with antioxidant enzymes, cell content leakage and finally downregulating the virulence gene by interfering with transcription and translation in E. coli. In future, CgAgNPs can be incorporated in formulations to break antibiotic resistance in antibiotic resistant pathogenic E. coli.

摘要

抗微生物药物耐药性是一个全球性问题,由于细菌产生的耐药性,抗生素的效果正在降低。在这项当前的研究中,从内生真菌胶孢炭疽菌(CgAgNPs)的水提物中合成了银纳米粒子,并通过多种方法进行了表征。通过对大肠杆菌 ATCC 25922 和抗生素耐药的致病性菌株进行抗菌试验分析了 CgAgNPs 的功效。在用 CgAgNPs 处理后,所有大肠杆菌菌株的生物膜形成均减少。体外细胞毒性试验表明,CgAgNPs 能够增加细胞膜通透性,并诱导糖和蛋白质的泄漏。CgAgNPs 在大肠杆菌菌株中诱导氧化应激导致脂质过氧化和丙二醛的释放。CgAgNPs 能够调节细胞的抗氧化系统,从而降低谷胱甘肽还原酶、过氧化氢酶和超氧化物歧化酶的活性。分析编码 CTX-M-15 的基因的表达表明,在用氨苄青霉素和 CgAgNPs 处理后,其表达下调。总的来说,这些结果表明,CgAgNPs 通过诱导氧化应激、干扰抗氧化酶、细胞内容物泄漏以及最终通过干扰转录和翻译来下调大肠杆菌中的毒力基因,从而控制大肠杆菌的生长和生物膜形成。在未来,可以将 CgAgNPs 纳入制剂中,以打破抗生素耐药性的致病性大肠杆菌中的抗生素耐药性。

相似文献

1
Antibacterial, antibiofilm, and antivirulence effects of nanoparticles synthesized from Colletotrichum gloeosporioides in pathogenic E.coli.由胶孢炭疽菌合成的纳米粒子对致病性大肠杆菌的抗菌、抗生物膜和抗毒力作用。
Microb Pathog. 2023 Dec;185:106420. doi: 10.1016/j.micpath.2023.106420. Epub 2023 Oct 23.
2
Unveiling the cytotoxic and anti-proliferative potential of green-synthesized silver nanoparticles mediated by .揭示由……介导的绿色合成银纳米颗粒的细胞毒性和抗增殖潜力。
RSC Adv. 2024 Jan 30;14(6):4074-4088. doi: 10.1039/d3ra06145k. eCollection 2024 Jan 23.
3
Lethal Mechanisms of -Synthesized Silver Nanoparticles Against Different Pathogenic Bacteria.-合成银纳米颗粒对不同病原菌的致死机制。
Int J Nanomedicine. 2020 Dec 29;15:10499-10517. doi: 10.2147/IJN.S289243. eCollection 2020.
4
Antimicrobial Applications of Silver Nanoparticles to E. coli Colony Biofilms.银纳米颗粒对大肠杆菌菌落生物膜的抗菌应用
Methods Mol Biol. 2020;2118:21-28. doi: 10.1007/978-1-0716-0319-2_2.
5
Antibacterial and antibiofilm efficacy of colistin & meropenem conjugated silver nanoparticles against Escherichia coli and Klebsiella pneumoniae.多黏菌素 E 与美罗培南偶联银纳米颗粒对大肠杆菌和肺炎克雷伯菌的抗菌和抗生物膜效果。
J Basic Microbiol. 2023 Dec;63(12):1397-1411. doi: 10.1002/jobm.202300440. Epub 2023 Oct 11.
6
Promising antimicrobial and antibiofilm activities of Orobanche aegyptiaca extract-mediated bimetallic silver-selenium nanoparticles synthesis: Effect of UV-exposure, bacterial membrane leakage reaction mechanism, and kinetic study.黄花列当提取物介导的双金属银-硒纳米粒子合成的有前景的抗菌和抗生物膜活性:UV 暴露的影响、细菌膜渗漏反应机制和动力学研究。
Arch Biochem Biophys. 2023 Mar 1;736:109539. doi: 10.1016/j.abb.2023.109539. Epub 2023 Feb 4.
7
Rhamnolipid-Coated Iron Oxide Nanoparticles as a Novel Multitarget Candidate against Major Foodborne E. coli Serotypes and Methicillin-Resistant S. aureus.杆菌脂-氧化铁纳米颗粒作为一种新型的多靶点候选物,可对抗主要食源性病原体大肠杆菌血清型和耐甲氧西林金黄色葡萄球菌。
Microbiol Spectr. 2022 Aug 31;10(4):e0025022. doi: 10.1128/spectrum.00250-22. Epub 2022 Jul 19.
8
Silver Decorated Myconanoparticles Control Growth and Biofilm Formation in Uropathogenic E. coli.银修饰的蕈状纳米粒子控制尿路致病性大肠杆菌的生长和生物膜形成。
Appl Biochem Biotechnol. 2022 Jan;194(1):504-516. doi: 10.1007/s12010-021-03692-9. Epub 2021 Oct 7.
9
Green Synthesized Silver Nanoparticles Using Lactobacillus Acidophilus as an Antioxidant, Antimicrobial, and Antibiofilm Agent Against Multi-drug Resistant Enteroaggregative Escherichia Coli.利用嗜酸乳杆菌绿色合成银纳米颗粒作为抗氧化、抗菌和抗生物膜剂对抗多重耐药性聚集性大肠杆菌
Probiotics Antimicrob Proteins. 2022 Oct;14(5):904-914. doi: 10.1007/s12602-022-09961-1. Epub 2022 Jun 17.
10
Biogenic nanosilver bearing antimicrobial and antibiofilm activities and its potential for application in agriculture and industry.具有抗菌和抗生物膜活性的生物源纳米银及其在农业和工业中的应用潜力。
Front Microbiol. 2023 Feb 20;14:1125685. doi: 10.3389/fmicb.2023.1125685. eCollection 2023.

引用本文的文献

1
Antimicrobial potential of floral extract-decorated nanoparticles against food-borne pathogens.花卉提取物修饰的纳米颗粒对食源性病原体的抗菌潜力。
Discov Nano. 2025 Jul 5;20(1):103. doi: 10.1186/s11671-025-04292-w.
2
Green Synthesis of Silver Nanoparticles Using centratherum anthelminticum Extract against Breast Cancer Cells.利用旋覆花提取物的绿色合成法制备银纳米粒子及其对乳腺癌细胞的抑制作用。
Asian Pac J Cancer Prev. 2024 Aug 1;25(8):2711-2721. doi: 10.31557/APJCP.2024.25.8.2711.